Heart Attack Risk

Heart attack risk tests help you measure the biology that drives plaque buildup and instability. While blood tests can’t show blocked arteries directly, they reveal atherogenic particle burdengenetic lipoproteinslow-grade inflammationglucose control, and kidney health—all key to long-term risk.

A practical plan starts with a standard lipid panel and A1c/glucose, then adds ApoB (particle number), lipoprotein(a) [Lp(a)] (genetic risk), and hs-CRP (inflammation) to sharpen the picture. Kidney markers (creatinine/eGFR and urine albumin-creatinine) add vascular context. When acute symptoms suggest a heart attack, troponin is used—this is not a routine screening test. Use results to guide prevention with your clinician; labs complement, not replace, blood-pressure control, ECGs, and imaging such as coronary artery calcium scoring when appropriate.

Signs, Symptoms & Related Situations

  • Prevention & baseline: strong family history of early heart attack or stroke; high LDL; high blood pressure; diabetes/prediabetes; central weight gain; high triglycerides; chronic kidney disease

  • Training & lifestyle checkpoints: starting a fitness or nutrition program; weight-loss efforts; reviewing statin or other lipid-lowering therapy; statin intolerance or limited LDL response

  • Possible acute symptoms (urgent): new or crushing chest pressure, shortness of breath at rest, fainting, jaw/arm pain, one-sided weakness, or trouble speaking—seek emergency care now

Why These Tests Matter

What testing can do

  • Refine risk beyond basic cholesterol using ApoBLp(a), and hs-CRP

  • Guide follow-up when results are borderline or discordant with your personal/family risk

  • Track trends after lifestyle changes or therapy adjustments

What testing cannot do

  • Diagnose blocked arteries or an active heart attack on its own

  • Replace guideline imaging (e.g., coronary calcium scan) or clinical evaluation for chest pain

  • Predict events with certainty without considering the full clinical picture

What These Tests Measure (at a glance)

  • Lipid Panel (TC, LDL-C, HDL-C, TG) and non-HDL-C: core cholesterol snapshot; non-HDL-C captures all atherogenic cholesterol.

  • Apolipoprotein B (ApoB): counts all atherogenic particles (VLDL remnants, IDL, LDL, Lp[a]); often more informative than LDL-C when triglycerides are high or results don’t fit the risk profile.

  • Lipoprotein(a) [Lp(a)]: genetically determined and mostly lifelong; raises risk of heart attack and calcific aortic valve disease regardless of LDL-C.

  • LDL Particle Number/Size (LDL-P, subfractions): particle burden and distribution; particle number typically carries the most weight.

  • High-sensitivity C-reactive protein (hs-CRP): marker of low-grade inflammation; interpret trends (illness and hard workouts can cause temporary spikes).

  • A1c and Fasting Glucose (± Insulin): glycemic control; insulin resistance accelerates atherosclerosis.

  • Kidney Markers: Creatinine/eGFR and urine albumin-creatinine; kidney health and microalbuminuria signal higher vascular risk.

  • High-sensitivity Troponin: detects acute heart-muscle injury—used for symptom-driven evaluations, not routine screening.

  • Optional context tests: ApoA-Iremnant cholesterol (RLP-C)Lp-PLA2homocysteineomega-3 index (if offered).

How the Testing Process Works

  1. Choose your starting set: order lipid panel A1c/glucose, then add ApoBLp(a), and hs-CRP for risk refinement.

  2. Prepare for accuracy: follow any fasting instructions; schedule on a recovery day; keep supplements consistent unless your order advises holds (biotin can affect some assays).

  3. Get your draw: visit a local patient service center; most results post within a few days.

  4. Review with your clinician: combine labs with age, blood pressure, smoking status, diabetes, family history, and—when indicated—coronary calcium or stress imaging.

  5. Track trends: recheck on a cadence tailored to your goals, risk level, and treatment plan.

Interpreting Results (General Guidance)

  • LDL-C & non-HDL-C: lower values generally reduce risk; non-HDL-C reflects all atherogenic cholesterol.

  • ApoB / LDL-P: higher numbers mean more atherogenic particles; particularly useful when triglycerides are elevated or LDL-C appears “okay” but risk is high.

  • Lp(a): treat elevation as added lifetime risk; levels are largely genetic and stable.

  • hs-CRP: look at trends; retest after illness or tough training.

  • A1c/Glucose & Kidney markers: better glycemic control and healthy kidneys lower cardiovascular risk.
    Always interpret results with a qualified healthcare professional; do not start or stop medications without guidance.

Choosing Panels vs. Individual Tests

  • Starter risk screen: Lipid Panel non-HDL-C A1c/Glucose

  • Risk refinement (family history or discordant results): ApoB Lp(a) hs-CRP (± LDL-P/subfractions)

  • Metabolic/high-TG focus: ApoBRLP-CLDL-P, and hs-CRP

  • Vascular-kidney context: Creatinine/eGFR Urine Albumin-Creatinine

  • Acute symptom pathway: Troponin only for urgent, symptom-driven evaluations per clinician

FAQs

Do I need to fast?
Follow your order. Many lipid panels can be non-fasting, but fasting is common and helpful when triglycerides are high.

Is ApoB more important than LDL-C?
They often align, but ApoB reflects particle number and can reveal risk when LDL-C looks acceptable.

Can I lower Lp(a) with lifestyle?
Lp(a) is genetic and usually stable. Healthy habits still reduce overall risk; discuss options with your clinician.

Will a low hs-CRP guarantee safety?
No. hs-CRP is one piece of the puzzle. Use it with cholesterol, blood pressure, glucose control, and imaging when appropriate.

How often should I repeat testing?
Commonly every 3–12 months, depending on goals and therapy. Your clinician will tailor the cadence.

Can these tests detect a heart attack in progress?
Only troponin helps assess acute injury, and it must be used in an urgent clinical evaluation. Call emergency services for new or severe chest pain.

Related Categories & Key Tests

  • Heart & Cardiovascular Tests Hub

  • Cardio IQ Tests • Coronary Artery Disease Tests • Cardiovascular Disease (CVD) Tests • Cholesterol Tests • Diabetes & Insulin Resistance • Kidney Health • Inflammation (hs-CRP)

  • Key Tests: Lipid Panel • non-HDL-C • ApoB • Lp(a) • LDL Particle Number/Size • hs-CRP • A1c/Glucose (± Insulin) • Creatinine/eGFR • Urine Albumin-Creatinine • Troponin (symptom-driven)

References

  • American College of Cardiology/American Heart Association — Cholesterol and primary prevention guidelines.
  • National Lipid Association — Scientific statements on ApoB, Lp(a), and remnant cholesterol.
  • European Atherosclerosis Society — Consensus on Lp(a).
  • AHA/CDC — Inflammation markers and cardiovascular risk.
  • KDIGO — Chronic kidney disease and albumin-creatinine testing guidance.
  • Clinical reviews on LDL particle metrics and residual risk.

Take Control of Your Heart Health

It’s quick, easy, and affordable to learn more about your cardiovascular health. Get started today by ordering the CVD – High Heart Health Risk Plus Lab Panel—or select the option that best fits your needs from our complete lineup below.

Key Cardiovascular Health Panels

  • CVD - 1. Low Heart Health Risk
    A starting point for individuals with no known risks who want to establish a baseline profile of their heart health.

  • CVD - 2. Moderate Heart Health Risk
    Ideal if you have some risk factors such as family history, high blood pressure, or elevated cholesterol.

  • CVD - 3. High Heart Health Risk
    Recommended if you have multiple risk factors or a history of cardiovascular concerns and want a deeper look at your biomarkers.

  • CVD - 4. High Heart Health Risk Plus
    Our most advanced panel, designed for individuals with significant risks or existing heart disease, offering the most comprehensive view of cardiovascular function.

Each panel measures a group of tests that shows how well your organs are working and provides an overall picture of your cardiovascular health—with fast, secure results available in just 24–48 hours.

Order your panel today and take the first step toward protecting your heart for the future.

 

Available Tests & Panels

Your Heart Attack Risk Tests menu is pre-populated in the Ulta Lab Tests system. Start with lipids A1c, add ApoBLp(a), and hs-CRP to refine risk, include kidney markers for vascular context, and reserve troponin for urgent, symptom-driven evaluations. Review results with your clinician to personalize prevention and follow-up.

 

  • Page
  • 1
  • of
  • 2
  • Total Rows
  • 49
Name Matches
Blood
Blood Draw, Phlebotomist

Blood, Varied
Blood Draw, Phlebotomist

Blood, Urine, Varied
Blood Draw, Phlebotomist, Urine Collection

Blood, Urine, Varied
Blood Draw, Phlebotomist, Urine Collection

The ADMA and SDMA Test measures asymmetric and symmetric dimethylarginine, biomarkers of nitric oxide metabolism and endothelial function. Elevated levels are linked to cardiovascular disease, kidney dysfunction, and metabolic disorders. Doctors order this test to assess vascular health, kidney function, or cardiovascular risk. Results provide critical insight into endothelial damage, early detection of disease, and guidance for preventive or therapeutic strategies.

Blood
Blood Draw
Also Known As: ADMA/SDMA Test

The Apolipoprotein A1 (Apo A1) Test measures levels of Apo A1, the main protein in HDL cholesterol, to assess heart and vascular health. Higher levels are linked to protective “good” cholesterol, while low levels may increase risk of heart disease, stroke, or metabolic disorders. Doctors use this test with lipid panels to evaluate cardiovascular risk, monitor therapy, and guide prevention strategies for cholesterol balance and heart health.

Blood
Blood Draw
Also Known As: Apo A1 Test, Apolipoprotein A-1 Test

The Apolipoprotein A1 and B Test measures Apo A1, the main protein in HDL cholesterol, and Apo B, the primary protein in LDL and VLDL cholesterol. Together, these markers and the ApoB/A1 ratio provide a clearer picture of cardiovascular risk than standard lipid panels. High ApoB or low Apo A1 may signal heart disease, stroke, or atherosclerosis. Doctors use this test to evaluate cholesterol balance, monitor therapy, and guide prevention of cardiovascular conditions.

Blood
Blood Draw
Also Known As: Apo A1 and B Test, Apolipoprotein Evaluation Test

The Apolipoprotein B (ApoB) Test measures ApoB, the main protein in LDL and VLDL cholesterol, to assess cardiovascular risk. Elevated ApoB is linked to atherosclerosis, coronary artery disease, heart attack, and stroke. Low levels may reflect liver disease or malnutrition. Doctors often order this test with lipid panels or Apo A1 to calculate the ApoB/A1 ratio, providing a more accurate picture of cholesterol balance, cardiovascular health, and risk for heart disease.

Blood
Blood Draw
Also Known As: Apo B Test, Apolipoprotein B-100 Test

Most Popular

The High-Sensitivity C-Reactive Protein (hs-CRP) Test measures very low levels of CRP in blood to evaluate inflammation and cardiovascular risk. Elevated hs-CRP may indicate increased risk for heart disease, heart attack, or stroke even before symptoms appear. Doctors use this test along with cholesterol and other markers to assess overall heart health, guide prevention strategies, and monitor treatment. It also helps evaluate chronic inflammation and metabolic conditions.

Blood
Blood Draw
Also Known As: Cardiac CRP Test, High Sensitivity C-Reactive Protein Test

The Cardio IQ™ ApoE Genotype Test analyzes apolipoprotein E (ApoE) gene variants linked to cholesterol metabolism and cardiovascular risk. Results help assess risk for heart disease, hyperlipidemia, and Alzheimer’s disease. This genetic test guides personalized prevention and treatment strategies, including diet, lifestyle, and lipid-lowering therapies, supporting long-term cardiovascular and brain health.

Blood
Blood Draw
Also Known As: ApoE Cardiac Risk Test, ApoE Cardiovascular Disease Test, Apolipoprotein E Test, Apo E Test, ApoE Protein Test

The Cardio IQ™ Lipoprotein Fractionation Ion Mobility Test separates and measures lipoprotein particles by size and concentration using ion mobility technology. It provides a detailed profile of LDL, HDL, and other subclasses, offering a clearer assessment of cardiovascular risk than standard cholesterol testing.

Blood
Blood Draw
Also Known As: LDL Particle Testing, LDL Subclass Test, LDL Fractionations Test

The NMR Lipoprotein Fractionation Test uses nuclear magnetic resonance to measure particle size and concentration of LDL, HDL, and VLDL cholesterol. Unlike a standard lipid panel, it provides detailed information on lipoprotein subfractions linked to cardiovascular risk. Doctors use this test to assess heart disease risk, guide cholesterol management, and monitor therapy effectiveness. It offers deeper insight into lipid metabolism and cardiovascular health.

Blood
Blood Draw
Also Known As: NMR Test, LDL Particle Testing, LDL Subclass Test, LDL Fractionations Test

The Cardio IQ™ Lp-PLA2 PLAC® Test measures lipoprotein-associated phospholipase A2, an enzyme linked to vascular inflammation and plaque instability. Elevated levels are associated with increased risk of coronary heart disease and ischemic stroke. Doctors use this blood test to assess cardiovascular risk beyond standard cholesterol testing, helping guide prevention and treatment strategies to reduce risk of heart attack or stroke.

Also Known As: LpPLA2 Test, Ps-PLA2 Activity Test, Lipoprotein-Associated Phospholipase A2 Test

The Cardio IQ™ Triglycerides Test measures triglyceride levels in the blood, an important marker of lipid metabolism and cardiovascular health. Elevated triglycerides are linked to increased risk of heart disease, pancreatitis, and metabolic syndrome. Physicians use this test to assess risk factors, monitor therapy response, and guide lifestyle or treatment decisions, often as part of a broader lipid or heart health evaluation.

Blood
Blood Draw

The Complete Blood Count with Differential and Platelets Test is a comprehensive blood test that checks red blood cells, white blood cells, hemoglobin, hematocrit, and platelets. The differential analyzes types of white blood cells to detect infections, anemia, clotting abnormalities, immune conditions, and certain cancers. This essential test is often ordered for routine health exams, diagnosis, and monitoring treatment progress.

Blood
Blood Draw
Also Known As: CBC Test, CBC with Differential and Platelets Test, CBC w/Diff and Platelets Test, Full Blood Count Test, Complete Blood Count Test

The Comprehensive Metabolic Panel (CMP) Test measures 21 markers to assess metabolic health, liver and kidney function, and electrolyte balance. It includes glucose, calcium, sodium, potassium, chloride, CO2, albumin, globulin, A/G ratio, total protein, bilirubin, ALP, AST, ALT, BUN, creatinine, BUN/creatinine ratio, and eGFR. The CMP helps detect diabetes, liver or kidney disease, and supports routine screening and chronic condition monitoring.

Blood
Blood Draw
Also Known As: CMP Test, Chemistry Panel Test, Chem Test, Chem 21 Test, Chem 14 Test 

The Creatine Kinase (CK) Total Test measures CK enzyme levels in blood to detect muscle injury, inflammation, or stress. Elevated CK may indicate muscle disorders, heart attack, strenuous exercise, or conditions such as rhabdomyolysis, while low levels are less common. Doctors use this test to evaluate unexplained muscle pain, weakness, or chest pain and to monitor recovery. It provides insight into muscle, cardiac, and overall metabolic health.

Blood
Blood Draw
Also Known As: CK Total Test, Creatine Phosphokinase, CPK Test

The Creatine Kinase (CK) Isoenzymes with Total CK Panel measures overall CK levels and breaks them into isoenzymes (CK-MM, CK-MB, CK-BB) to identify muscle, heart, or brain injury. Elevated CK-MB may suggest a heart attack, while CK-MM points to skeletal muscle damage, and CK-BB indicates brain injury. Doctors order this test for chest pain, muscle weakness, or trauma. Results provide critical insight for diagnosing and monitoring tissue damage.

Also Known As: CPK Isoenzymes Test

The Cystatin C Test with eGFR measures blood levels of Cystatin C, a protein filtered by the kidneys, and calculates estimated glomerular filtration rate (eGFR). This test provides a sensitive marker for kidney function and can detect early kidney disease, even when creatinine levels are normal. Doctors order it to evaluate chronic kidney disease risk, monitor treatment, and assess overall kidney health in patients with diabetes, hypertension, or other conditions.

Blood
Blood Draw
Also Known As: CysX Test, CysC Test

The Fibrinogen Activity Test measures how well fibrinogen, a key clotting protein, helps blood form clots. Low fibrinogen may indicate excessive bleeding, liver disease, or disseminated intravascular coagulation (DIC), while high levels may signal inflammation or increased clotting risk. Doctors use this test to evaluate unexplained bleeding, monitor clotting disorders, or assess liver function. Results provide vital insight into coagulation health and treatment management.

Varied
Phlebotomist
Also Known As: Factor 1 Assay Test, Cardiac Fibrinogen Test, Clotting Factors Test

The Galectin-3 Test measures levels of galectin-3, a biomarker linked to heart failure, cardiac fibrosis, and inflammation. Elevated results may indicate worsening heart disease, increased risk of hospitalization, or progression of chronic conditions. Doctors use this blood test to assess heart health, guide treatment decisions, and monitor patients with heart failure, offering valuable insight into long-term cardiovascular risk and management.

Blood
Blood Draw

Most Popular

The GGT Test measures gamma-glutamyl transferase, an enzyme found in the liver and bile ducts, to evaluate liver health. Elevated GGT may indicate liver disease, bile duct obstruction, alcohol use, or medication side effects. Doctors order this test to investigate symptoms like fatigue, jaundice, dark urine, or abdominal pain and to monitor liver damage. It is often performed with other liver tests to provide a complete picture of liver and bile duct function.

Blood
Blood Draw
Also Known As: Gamma Glutamyl Transferase Test, Gamma Glutamyl TransPeptidase Test, GGTP Test, GTP Test

Most Popular

The Homocysteine Test measures homocysteine levels in blood to assess risk for heart disease, stroke, and vascular problems. Elevated homocysteine may result from vitamin B6, B12, or folate deficiency and is linked to blood clots, cognitive decline, and osteoporosis. Doctors use this test to evaluate cardiovascular risk, monitor nutritional deficiencies, and guide treatment for metabolic or genetic conditions affecting homocysteine metabolism.

Blood
Blood Draw
Also Known As: Homocysteine Cardiac Risk Test

Most Popular

The Lipid Panel Test checks six key blood lipids: total cholesterol, HDL cholesterol, LDL cholesterol, non-HDL cholesterol, triglycerides, and the Chol/HDL ratio. This panel assesses risk for cardiovascular disease, heart attack, and stroke by evaluating cholesterol balance and fat levels in the blood. Doctors use lipid panel results for routine screening, treatment monitoring, and guiding lifestyle or medication adjustments.

Also Known As:  Lipid Profile Test, Cholesterol Panel Test, Lipids Blood Test 

The Lipid Panel Test with Reflex to Direct LDL measures total cholesterol, HDL, LDL, triglycerides, and cholesterol ratios to assess heart and vascular health. If triglycerides are very high, it automatically reflexes to direct LDL measurement for greater accuracy. Doctors use this test to evaluate cardiovascular risk, guide cholesterol management, and monitor therapy. Results provide key insight into lipid balance, heart disease prevention, and metabolic health.

Also Known As: Lipid Profile with Reflex Test, Lipids with Reflex Test, Cholesterol Profile with Reflex Test

Also referred to as an acute myocardial infarct, a heart attack occurs when an artery blockage prevents blood from flowing to a portion of a person’s heart. Heart tissue can be damaged or even destroyed if someone isn’t treated swiftly. A heart attack can be fatal. The American Heart Association states that approximately 735,000 people in the United States experience heart attacks each year. Around 120,000 of those people do not survive.  

The symptoms and signs linked with insufficient blood flowing to the heart are referred to as Acute coronary syndrome (ACS). What separates a heart attack from other types of ACS is that the decrease in blood flows continues, which causes heart muscle cells to be damaged or destroyed. If someone is brought into the ER, healthcare workers need to run tests to see if the symptoms are caused by a heart attack or something else.  

The human heart is an organ that’s primarily made from cardiac muscle. It uses a system of arteries and veins to pump blood through the body. As blood flows through the human body, it picks up oxygen from the lungs. The blood then passes through the pulmonary veins and enters the heart. The blood is then pumped out, bringing oxygen to the tissues. The veins return the blood to the heart, where it is pumped back out to collect more oxygen from the lungs. The heart is unable to carry out these tasks without a significant amount of oxygen, which is obtained from the heart’s network of arteries and veins.  

In most cases, a blockage that leads to a heart attack occurs because of a blood clot in a coronary artery, the arteries that bring blood to the heart. This is more likely to happen when the walls of the arteries are thickened and narrowed. This occurs via a process known as atherosclerosis, which causes plaque to build up on artery walls gradually. If a clot in a coronary artery keeps blood from flowing to the heart for more than an hour, it can cause scarring in that area. Furthermore, it can cause heart muscle cells to die.  

Risks  

Several factors can increase the risk of a heart attack, such as: 

  • High cholesterol  
  • High blood pressure  
  • Obesity  
  • A sedentary lifestyle  
  • Diabetes  
  • Advanced age  
  • A smoking habit  
  • History of heart disease in the family  
  • Drug use  
  • Stress  
  • Autoimmune conditions like rheumatoid arthritis or lupus  
  • Pre-eclampsia, which is linked with high blood pressure in pregnancy  

Symptoms and Warning Signs  

Heart attacks and other types of acute coronary syndrome often cause abrupt pain in the chest. The pain frequently radiates into other body parts, such as the arm, shoulder, or jaw, and does not go away with rest. In some cases, this is a more intense version of reoccurring pain, but in other cases, people are experiencing this pain for the first time.  

If someone has already experienced chest pain because their narrowed arteries do not allow an adequate amount of blood to flow to the heart, they may find that these symptoms are more intense or last for a more extended period of time.  

It should be noted that not all people that have heart attacks experience this symptom. It is more likely that women will experience atypical symptoms. Women often experience milder symptoms, which are frequently attributed to another cause. A heart attack can occur abruptly, but it’s also possible for symptoms to slowly build up over time. People may find that their symptoms stop and then return in some cases.  

Some common signs and symptoms are:  

  • Discomfort, pain, or pressure in the chest (this is the most common symptom)  
  • Elevated heart rate or skipping a heartbeat  
  • Stomach pain, nausea, and vomiting  
  • Shortness of breath or difficulty breathing  
  • Sweating  
  • Lightheadedness  
  • Fatigue  
  • Blood pressure changes  
  • Pain in the arms, back, neck, or jaw  

People can experience these symptoms without feeling any chest pain, especially if they’re older or diabetic.  

Testing for A Heart Attack  

If a patient arrives at the ER showing acute coronary syndrome symptoms, it’s not always immediately apparent that they are experiencing a heart attack. Their chest pain could have another cause, or they may be dealing with unstable angina. Thankfully, there is a range of tests that allow healthcare workers to determine whether a heart attack occurs.  

Laboratory Tests  

Typically, it’s necessary to run a blood test to determine whether someone has suffered a heart attack. When muscle cells are damaged, specific proteins are released. To see if a patient has suffered a heart attack, cardiac biomarkers are ordered, such as: 

Troponin: This is the marker that is most frequently ordered. It’s focused on the heart. Troponin blood levels will be elevated in the hours after heart damage has occurred. These levels can remain elevated for as long as two weeks. If a patient arrives in the emergency room showing acute coronary syndrome symptoms, troponin tests will likely be ordered right away. Over the next few hours, these tests will be ordered a few more times to monitor concentration changes. If the tests show normal levels, stable angina is likely causing the pain, not heart muscle damage. However, if the results show levels rising or falling, it’s a clear indicator of a heart attack.  

A high-sensitivity troponin test is like the standard test, but it can detect this protein at lower levels. Since this is a more sensitive version of the test, it can deliver positive results more quickly, allowing doctors to diagnose a heart attack more quickly. The test can also show a patient’s risk of heart attacks and other heart events in the future. The test can be positive even if a person has no symptoms. The test is not approved in the United States at writing, but research is still being conducted. It may be available at a future date. Canada, Europe, and several other countries already use this test as a cardiac biomarker. 

CK-MB – This is a form of the creatine kinase that can be found in cardiac muscle tissue. When the cells of the heart muscle are damaged, it rises. Now that troponin testing is an option, this test isn’t ordered as often.  

Additional tests that could be ordered are:  

Myoglobin – When there is an injury to either the heart or skeletal muscle, this protein is released into the blood. This is another test that is ordered less often.  

NT-proBNP or BNP – The body naturally releases this in response to heart failure. Although elevated BNP levels aren’t enough to diagnose a heart attack, it suggests that a person is at an increased risk for cardiac problems.  

Additional screening tests could be ordered to look at a patient’s electrolyte balance, organ health, blood glucose levels, and red and white blood cell count. Examples of these tests are:  

Comprehensive Metabolic Panel – This is a collection of 14 tests that can broadly screen the health of a patient’s liver, kidneys, blood proteins, blood glucose, and electrolyte and acid balance.  

Complete Blood Count: This test is used to screen for various disorders that can impact blood cells, like infection and anemia. 

The American Heart Association has released new cholesterol guidelines in unison with the American College of Cardiology. The premise behind these new guidelines is to understand and analyze the personal risk of cardiovascular disease (CVD) along with appropriate treatment options. These guidelines are now set as the standard by more than ten well-established medical organizations. These guidelines will make it easier to tailor recommendations and/or treatment plans using risk assessment processes. These treatments will encompass a variety of solutions, including statin/non-statin drug therapies. 

A person that has been diagnosed with high cholesterol regardless of age can end up having a heightened risk profile for cardiovascular disease. Due to this high cholesterol, the blood vessels start to constrict because of the newly formed plaque. Based on this premise, the AHC guideline panel has taken the time to highlight what’s required during the decision-making process between healthcare professionals and their patients. These guidelines have been updated for the first time since 2013 with a greater assessment of lifetime risks for cardiovascular disease in combination with treatment options for lowering cholesterol levels.  

Medical concerns involving heart disease, strokes, and heart attacks continue to plague Americans across the nation. Studies show over 836,000 people pass away in the U.S. due to this disease, with the number being greater than cancer-related or lung disease-related deaths. Along with these numbers, 360,000 people pass away due to coronary heart disease and 114,000 from heart attacks. It’s also important to note the presence of reoccurring heart attacks in America, which account for 335,000 cases in America per year.  

These AHA guidelines will include a standardized risk calculator to determine a person’s risk profile for a possible cardiovascular event (i.e., stroke, heart attack) within the next decade. This calculator includes pre-determined guidelines from 2013, such as smoking, diabetes, high blood pressure, and unhealthy lipid levels, while also accounting for additional factors such as aspirin therapy and/or statin treatment. This risk calculator will act as a standardized method to determine a person’s risk profile while also accumulating personalized data from previous health exams. 

Healthcare professionals are also asked to highlight the following risk variables to their patients: 

It’s important to note; these AHA guidelines are aimed at helping to diagnose high LDL levels before providing appropriate lowering solutions. The goal is to help lower LDL levels to approximately 70 mg/dL or less for high-risk patients. This recommendation was removed during the 2013 guidelines but has found its way back in the recent update. The emphasis is on taking these new guidelines to pinpoint a specific coronary artery calcium score (via a cardiac CT scan) and assessing statin therapy in those with intermediate CVD risk.  

These guidelines are all about shedding light on potential risk factors to patients with a greater likelihood of being diagnosed with cardiovascular disease. When those patients recognize these signs and start implementing preventive measures, it becomes easier to alleviate the possibility of heart disease or heart attack. These lifestyle changes include implementing a healthier diet, not smoking, and/or following a regular exercise regimen. 

Healthcare practitioners can use these guidelines as a risk assessment tool while maintaining communication with their patients. This leads to improved and personalized decision-making due to the guidelines. It’s essential to personalize the treatment plan based on a patient’s medical history, medications, and/or lifestyle.  

Based on new-age research, statins continue to be the best way to help lower LDL levels and can be used in different forms depending on an individual’s medical requirements. Additional non-statin drug therapies involving PCSK9 inhibitors and/or ezetimibe can be used for high-risk patients to lower their LDL levels.